Team:ITESM-CEM/Project/Data
From 2014.igem.org
AENCARNACION (Talk | contribs) |
AENCARNACION (Talk | contribs) |
||
(31 intermediate revisions not shown) | |||
Line 92: | Line 92: | ||
- | <a name="One"><h2>PCR's for | + | <a name="One"><h2>PCR's for sequence isolation</h2></a> |
<p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/b/ba/PCR_gel_1.jpg" width="217" height="336" hspace="20" BORDER=10></p><br> | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/b/ba/PCR_gel_1.jpg" width="217" height="336" hspace="20" BORDER=10></p><br> | ||
- | <p><pie><b>Gel 1.</b>High Fidelity PCRs Electrophoresis Gel . Well content: | + | <p><pie><b>Gel 1.</b>High Fidelity PCRs Electrophoresis Gel . Well content: 1) NeoR PCR(786pb) 2)CMV Promoter PCR(588bp) 3) f1ori PCR 4) BGHPA PCR (228bp).</p></pie><br> |
Line 117: | Line 117: | ||
<p style="text-align: justify; text-justify: inter-word;">The ligation (view material and methods) of CMV was made with J04450 (psB1C3 with RFP protein). The BB_J04450 by itself produces red colonies and grows in the antibiotic Cloramphenicol. After the ligation and transformation, only the white colonies were selected. An extraction from a white colony growing on 50ml LB Cam+ was made in order to perform gel electrophoresis as shown in figure B.</p><br> | <p style="text-align: justify; text-justify: inter-word;">The ligation (view material and methods) of CMV was made with J04450 (psB1C3 with RFP protein). The BB_J04450 by itself produces red colonies and grows in the antibiotic Cloramphenicol. After the ligation and transformation, only the white colonies were selected. An extraction from a white colony growing on 50ml LB Cam+ was made in order to perform gel electrophoresis as shown in figure B.</p><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/6/6c/IMG-20141016-WA0010.jpg" width="500" height="308" hspace="20" BORDER=10></p><br> |
<p><pie><b>Figure A.</b> Isolated CMV transformed colony. </p></pie><br> | <p><pie><b>Figure A.</b> Isolated CMV transformed colony. </p></pie><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/e/e9/PCR_gel_3.jpg" width="300" height="437" hspace="20" BORDER=10></p><br> |
<p><pie><b>Figure B.</b> CMV in plasmid psB1C3 gel electrophoresis. Lanes 1-3. </p></pie><br> | <p><pie><b>Figure B.</b> CMV in plasmid psB1C3 gel electrophoresis. Lanes 1-3. </p></pie><br> | ||
Line 129: | Line 129: | ||
<p style="text-align: justify; text-justify: inter-word;">The ligation (view material and methods) of NeoR was made with J04450 (psB1C3 with RFP protein). The BB_J04450 by itself produces red colonies and grows in the antibiotic Cloramphenicol. After the ligation and transformation 8 (Figure A), only the white colonies were selected. An extraction from a white colony growing on 50ml LB Cam+ was made in order to perform gel electrophoresis as shown in Figure B. On lane 8, NeoR extraction is shown with the three bands isoforms, they are barely visible because the plasmid extraction was diluted 5 fold.</p><br> | <p style="text-align: justify; text-justify: inter-word;">The ligation (view material and methods) of NeoR was made with J04450 (psB1C3 with RFP protein). The BB_J04450 by itself produces red colonies and grows in the antibiotic Cloramphenicol. After the ligation and transformation 8 (Figure A), only the white colonies were selected. An extraction from a white colony growing on 50ml LB Cam+ was made in order to perform gel electrophoresis as shown in Figure B. On lane 8, NeoR extraction is shown with the three bands isoforms, they are barely visible because the plasmid extraction was diluted 5 fold.</p><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/a/ab/IMG-20141016-WA0012.jpg" width="210" height="373" hspace="20" BORDER=10></p><br> |
<p><pie><b>Figure A.</b> Isolated NeoR transformed colony. </p></pie><br> | <p><pie><b>Figure A.</b> Isolated NeoR transformed colony. </p></pie><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/d/d1/PCR_gel_4.jpg" width="500" height="308" hspace="20" BORDER=10></p><br> |
<p><pie><b>Figure B.</b> NeoR in plasmid psB1C3 gel electrophoresis.<br> Lanes:<br> 2-4. NeoR in psB1C3 digestion with XhoI. <br> 6-8. NeoR in psB1C3. <br> 10-12. CMV in psB1C3. <br> </p></pie><br> | <p><pie><b>Figure B.</b> NeoR in plasmid psB1C3 gel electrophoresis.<br> Lanes:<br> 2-4. NeoR in psB1C3 digestion with XhoI. <br> 6-8. NeoR in psB1C3. <br> 10-12. CMV in psB1C3. <br> </p></pie><br> | ||
Line 145: | Line 145: | ||
<p style="text-align: justify; text-justify: inter-word;">A digestion proof of the CMV construction in pSB1C3 is shown on lane 1 (Figure A); when compared to the analysis performed in silico (Figure B), both band patterns coincided.</p><br> | <p style="text-align: justify; text-justify: inter-word;">A digestion proof of the CMV construction in pSB1C3 is shown on lane 1 (Figure A); when compared to the analysis performed in silico (Figure B), both band patterns coincided.</p><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/e/ee/PCR_gel_5.jpg" width="350" height="468" hspace="20" BORDER=10></p><br> |
<p><pie><b>Figure A.</b> Lane 5. CMV digestion with XhoI. </p></pie><br> | <p><pie><b>Figure A.</b> Lane 5. CMV digestion with XhoI. </p></pie><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/5/5d/PCR_in_silico_1.jpg" width="600" height="290" hspace="20" BORDER=10></p><br> |
- | + | ||
<p><pie><b>Figure B.</b> In silico CMV-psB1C3 digestion. </p></pie><br> | <p><pie><b>Figure B.</b> In silico CMV-psB1C3 digestion. </p></pie><br> | ||
Line 157: | Line 156: | ||
<p style="text-align: justify; text-justify: inter-word;">On the second, third and fourth lanes we can see the NeoR in pSB1C3 digestion with XhoI (Figure A). Even though dim bands can be seen because of the dilution of the original extraction, the banding pattern complies with what was expected from the in silico digestion of this construct (Figure B). The longest DNA fragment is undigested plasmid.</p><br> | <p style="text-align: justify; text-justify: inter-word;">On the second, third and fourth lanes we can see the NeoR in pSB1C3 digestion with XhoI (Figure A). Even though dim bands can be seen because of the dilution of the original extraction, the banding pattern complies with what was expected from the in silico digestion of this construct (Figure B). The longest DNA fragment is undigested plasmid.</p><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/4/4f/PCR_gel_6.jpg" width="600" height="370" hspace="20" BORDER=10></p><br> |
<p><pie><b>Figure A.</b> Lanes 2-4. NeoR digestion with XhoI. </p></pie><br> | <p><pie><b>Figure A.</b> Lanes 2-4. NeoR digestion with XhoI. </p></pie><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/d/d4/PCR_in_silico_2.jpg" width="600" height="337" hspace="20" BORDER=10></p><br> |
<p><pie><b>Figure B.</b> In silico NeoR-psB1C3 digestion. </p></pie><br> | <p><pie><b>Figure B.</b> In silico NeoR-psB1C3 digestion. </p></pie><br> | ||
Line 169: | Line 168: | ||
<p style="text-align: justify; text-justify: inter-word;">A digestion proof of the BGHPA construction in pSB1C3 is shown on lane 5 (Figure A). When compared to the analysis performed in silico (Figure B), both band patterns coincided.</p><br> | <p style="text-align: justify; text-justify: inter-word;">A digestion proof of the BGHPA construction in pSB1C3 is shown on lane 5 (Figure A). When compared to the analysis performed in silico (Figure B), both band patterns coincided.</p><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/a/a1/PCR_gel_7.jpg" width="350" height="450" hspace="20" BORDER=10></p><br> |
<p><pie><b>Figure A.</b> Lane 5. BGHPA digestion with XhoI. </p></pie><br> | <p><pie><b>Figure A.</b> Lane 5. BGHPA digestion with XhoI. </p></pie><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/b/b7/In_silico_3.jpg" width="600" height="277" hspace="20" BORDER=10></p><br> |
<p><pie><b>Figure B.</b> In silico BGHPA-psB1C3 digestion. </p></pie><br> | <p><pie><b>Figure B.</b> In silico BGHPA-psB1C3 digestion. </p></pie><br> | ||
Line 183: | Line 182: | ||
<h4>7-Dehydratase in mammalian expression plasmid</h4><br> | <h4>7-Dehydratase in mammalian expression plasmid</h4><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/0/01/Gel11.jpg" width="300" height="348" hspace="20" BORDER=10></p><br> |
+ | |||
<p><pie><b>Figure 1.</b> Gel electrophoresis 0.8% agarose. 7-dehydratase plasmid extraction. Lanes: 1, Invitrogen 1Kb Plus Ladder (5uL). 2, unknown sample. 3, 7-dehydratase in pcDNA 3.1 Myc-His A plasmid extraction. (5 uL) | <p><pie><b>Figure 1.</b> Gel electrophoresis 0.8% agarose. 7-dehydratase plasmid extraction. Lanes: 1, Invitrogen 1Kb Plus Ladder (5uL). 2, unknown sample. 3, 7-dehydratase in pcDNA 3.1 Myc-His A plasmid extraction. (5 uL) | ||
Line 190: | Line 190: | ||
<p style="text-align: justify; text-justify: inter-word;">The image below shows the presence of the correct ligation of 7-dehydratase in pcDNA 3.1 Myc-His A. No RNA or protein contamination is to be seen.</p><br> | <p style="text-align: justify; text-justify: inter-word;">The image below shows the presence of the correct ligation of 7-dehydratase in pcDNA 3.1 Myc-His A. No RNA or protein contamination is to be seen.</p><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/7/77/Gel12.jpg" width="600" height="210" hspace="20" BORDER=10></p><br> |
<p><pie><b>Figure 2.</b> In silico restriction analysis of sense insertion of 7-dehydratase in pcDNA 3.1 Myc-His A. Three fragments are generated with XhoI and ScaI.</p></pie><br> | <p><pie><b>Figure 2.</b> In silico restriction analysis of sense insertion of 7-dehydratase in pcDNA 3.1 Myc-His A. Three fragments are generated with XhoI and ScaI.</p></pie><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/1/1f/Gel13.jpg" width="600" height="242" hspace="20" BORDER=10></p><br> |
<p><pie><b>Figure 3.</b> In silico restriction analysis of anti-sense insertion of 7-dehydratase in pcDNA 3.1 Myc-His A. Three fragments are generated with XhoI and ScaI.</p></pie><br> | <p><pie><b>Figure 3.</b> In silico restriction analysis of anti-sense insertion of 7-dehydratase in pcDNA 3.1 Myc-His A. Three fragments are generated with XhoI and ScaI.</p></pie><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/f/f1/Gel14.jpg" width="250" height="403" hspace="20" BORDER=10></p><br> |
- | + | ||
<p><pie><b>Figure 4.</b>7-dehydratase plasmid restriction. Lanes: 1, Invitrogen 1Kb Plus Ladder. 2, unknown sample. 3, unknown sample. 4, 7-dehydratase in pcDNA 3.1 Myc-His A plasmid extraction.</p></pie><br> | <p><pie><b>Figure 4.</b>7-dehydratase plasmid restriction. Lanes: 1, Invitrogen 1Kb Plus Ladder. 2, unknown sample. 3, unknown sample. 4, 7-dehydratase in pcDNA 3.1 Myc-His A plasmid extraction.</p></pie><br> | ||
Line 208: | Line 207: | ||
<p style="text-align: justify; text-justify: inter-word;">Once a construction which included the biobricks CMV promoter, and BGHPA polyadenylation signal was built, using GFP (BBa_E0240) as a marker of gene expression; the plasmid was transfected into monkey kidney cells (MARC-145 cell line) using the protocol previously described (see Materials and Methods) in order to assess its functionality in an eukaryotic environment. A photograph of the cells before transfection, taken with an inverted phase microscope, is shown in figure 1.</p><br> | <p style="text-align: justify; text-justify: inter-word;">Once a construction which included the biobricks CMV promoter, and BGHPA polyadenylation signal was built, using GFP (BBa_E0240) as a marker of gene expression; the plasmid was transfected into monkey kidney cells (MARC-145 cell line) using the protocol previously described (see Materials and Methods) in order to assess its functionality in an eukaryotic environment. A photograph of the cells before transfection, taken with an inverted phase microscope, is shown in figure 1.</p><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/0/06/C%C3%A9lulas_antes_de_transfectar.jpg" width="500" height="372" hspace="20" BORDER=10></p><br> |
<p><pie><b>Figure 1.</b> MARC-145 cells before transfection as seen with an inverted phase microscope. </p></pie><br> | <p><pie><b>Figure 1.</b> MARC-145 cells before transfection as seen with an inverted phase microscope. </p></pie><br> | ||
Line 215: | Line 214: | ||
<p style="text-align: justify; text-justify: inter-word;">Another photograph was taken using the inverted phase microscope 48 hours after transfection. Two control experiments were run: one without lipofectamine, and another one with lipofectamine and no plasmid. Figure 2 shows a comparison between both controls and the experiment. Cell growth exists for all samples because Geneticin selection cannot yet be measured.</p><br> | <p style="text-align: justify; text-justify: inter-word;">Another photograph was taken using the inverted phase microscope 48 hours after transfection. Two control experiments were run: one without lipofectamine, and another one with lipofectamine and no plasmid. Figure 2 shows a comparison between both controls and the experiment. Cell growth exists for all samples because Geneticin selection cannot yet be measured.</p><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/f/f8/Controles_y_GFP_depsues_de_transfecci%C3%B3n.JPG" width="560" height="143" hspace="20" BORDER=10></p><br> |
+ | |||
<p><pie><b>Figure 2.</b> From left to right, control cells treated with no lipofectamine, control cells treated with lipofectamine and no plasmid and cells exposed to lipofectamine and plasmid. Photographs were taken using an inverted phase microscope. Cell growth is seen for all the experiments. </p></pie><br> | <p><pie><b>Figure 2.</b> From left to right, control cells treated with no lipofectamine, control cells treated with lipofectamine and no plasmid and cells exposed to lipofectamine and plasmid. Photographs were taken using an inverted phase microscope. Cell growth is seen for all the experiments. </p></pie><br> | ||
Line 221: | Line 221: | ||
<p style="text-align: justify; text-justify: inter-word;">Since cell growth exists for all cultures, the experiment was treated with UV light at 395nm in order to asses for fluorescence, which would be a proof of gene expression. The results of this analysis are shown in figure 3, where fluorescence can be seen. However, it can be easily seen that transfection efficiency is not as high as predicted.</p><br> | <p style="text-align: justify; text-justify: inter-word;">Since cell growth exists for all cultures, the experiment was treated with UV light at 395nm in order to asses for fluorescence, which would be a proof of gene expression. The results of this analysis are shown in figure 3, where fluorescence can be seen. However, it can be easily seen that transfection efficiency is not as high as predicted.</p><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/6/61/Fluorescencia_despu%C3%A9s_de_transfecci%C3%B3n.jpg" width="500" height="373" hspace="20" BORDER=10></p><br> |
<p><pie><b>Figure 3.</b> Lipofected cells containing the GFP-expressing device exposed to UV radiation. Lipofection efficiency is low but construction funtionality is proven by the fluorescence observed. </p></pie><br> | <p><pie><b>Figure 3.</b> Lipofected cells containing the GFP-expressing device exposed to UV radiation. Lipofection efficiency is low but construction funtionality is proven by the fluorescence observed. </p></pie><br> | ||
Line 229: | Line 229: | ||
<p style="text-align: justify; text-justify: inter-word;">Finally, figure 4 shows the results for transfection of a construction including CMV promoter, BGHPA, and one of the enzymes cloned by the team (7-dehidratase). However, due to a lack of time, characterization of gene expression for this construction was not performed.</p><br> | <p style="text-align: justify; text-justify: inter-word;">Finally, figure 4 shows the results for transfection of a construction including CMV promoter, BGHPA, and one of the enzymes cloned by the team (7-dehidratase). However, due to a lack of time, characterization of gene expression for this construction was not performed.</p><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/a/a5/Dehidratasa_despu%C3%A9s_de_transfecci%C3%B3n.jpg" width="500" height="373" hspace="20" BORDER=10></p><br> |
<p><pie><b>Figure 4.</b> Lipofected cells containing the 7-dehydratase expressing plasmid construction as seen after transfection. </p></pie><br> | <p><pie><b>Figure 4.</b> Lipofected cells containing the 7-dehydratase expressing plasmid construction as seen after transfection. </p></pie><br> | ||
Line 257: | Line 257: | ||
</p> | </p> | ||
- | <p | + | <p><pie><b>Image 1.</b>Comparative graph showing cell number per ml in both groups.</p></pie><br> |
- | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/ | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/9/9b/GraficaneoR.jpg" height="297" width="600" align="middle" hspace="10" BORDER=10><br></p><br> |
- | <p | + | <p><pie><b>Table 1.</b>CFU count</p></pie><br> |
- | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/d/da/Tabla3_neor.jpg" height=" | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/d/da/Tabla3_neor.jpg" height="179" width="600" align="middle" hspace="10" BORDER=10><br></p><br> |
+ | |||
+ | <p style="text-align: justify; text-justify: inter-word;">Based on the CFU count, the neomycin concentration expected to properly work as a selective antibiotic is 100 ug/ml and above. Any concentration below this point showed colonies in forms of clusters which were sometimes impossible to quantify and therefore it could be the cause of experimental difficulties to obtain isolated colonies.</p><br> | ||
<gotop><a href="#top">Back to top ↑</a></gotop><br><br> | <gotop><a href="#top">Back to top ↑</a></gotop><br><br> | ||
Line 269: | Line 271: | ||
<a name="Six"><h2>Enzymes</h2></a> | <a name="Six"><h2>Enzymes</h2></a> | ||
- | <h4> | + | <h4>BBa_K1313000</h4> |
+ | |||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/4/4a/Colo2.png" height="400" width="392" align="middle" hspace="10" BORDER=10><br></p><br> |
<p><pie><b>Figure 1.</b> Growth of isolated white colony showing a successful transformation with cholesterol oxidase enzyme in LB plate with chloramphenicol (35 mg/ul).</p></pie><br> | <p><pie><b>Figure 1.</b> Growth of isolated white colony showing a successful transformation with cholesterol oxidase enzyme in LB plate with chloramphenicol (35 mg/ul).</p></pie><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/7/78/Colo25.png" height="329" width="418" align="middle" hspace="10" BORDER=10><br></p><br> |
<p><pie><b>Figure 2.</b>Gel electrophoresis 0.8% agarose. Extraction of cholesterol oxidase enzyme ligated in psB1C3 (September 5th, 2014) Lane M: Marker Invitrogen DNA Ladder 1kb Plus (5 uL), Lane 5: Cholesterol oxidase in pSB1C3 plasmid (5uL). | <p><pie><b>Figure 2.</b>Gel electrophoresis 0.8% agarose. Extraction of cholesterol oxidase enzyme ligated in psB1C3 (September 5th, 2014) Lane M: Marker Invitrogen DNA Ladder 1kb Plus (5 uL), Lane 5: Cholesterol oxidase in pSB1C3 plasmid (5uL). | ||
Line 282: | Line 285: | ||
<p style="text-align: justify; text-justify: inter-word;">The image below shows the presence of the correct ligation of Cholesterol oxidase in pSB1C3.</p><br> | <p style="text-align: justify; text-justify: inter-word;">The image below shows the presence of the correct ligation of Cholesterol oxidase in pSB1C3.</p><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/7/7a/Colo253.png" height="268" width="600" align="middle" hspace="10" BORDER=10><br></p><br> |
<p><pie><b>Figure 3.</b> In silico restriction analysis of psB1C3 with cholesterol oxidase. Fragments generated with PstI and EcoRI.</p></pie><br> | <p><pie><b>Figure 3.</b> In silico restriction analysis of psB1C3 with cholesterol oxidase. Fragments generated with PstI and EcoRI.</p></pie><br> | ||
Line 288: | Line 291: | ||
<p style="text-align: justify; text-justify: inter-word;">Comparing the analysis of restriction in silico of cholesterol oxidase in pSB1C3 (Figure 3) against the electrophoresis gel shown in the image below, the two expected bands can be seen (2033 bp, 956 bp. Shown in boxes.) This shows that the enzyme was correctly inserted into the plasmid.</p> | <p style="text-align: justify; text-justify: inter-word;">Comparing the analysis of restriction in silico of cholesterol oxidase in pSB1C3 (Figure 3) against the electrophoresis gel shown in the image below, the two expected bands can be seen (2033 bp, 956 bp. Shown in boxes.) This shows that the enzyme was correctly inserted into the plasmid.</p> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/8/8d/Colosd.png" height="487" width="343" align="middle" hspace="10" BORDER=10><br></p><br> |
<p><pie><b>Image 4.</b>Gel electrophoresis 0.8% agarose. Cholesterol oxidase restriction with EcoRI and PstI (September 23th, 2014) Lane M: Marker Invitrogen DNA Ladder 1kb Plus (5 uL), Lane 1: Undigested cholesterol oxidase (5 uL), Lane 2 and 3: empty, Lane 4: Cholesterol oxidase enzyme digestion with EcoRI and PstI (10 uL). | <p><pie><b>Image 4.</b>Gel electrophoresis 0.8% agarose. Cholesterol oxidase restriction with EcoRI and PstI (September 23th, 2014) Lane M: Marker Invitrogen DNA Ladder 1kb Plus (5 uL), Lane 1: Undigested cholesterol oxidase (5 uL), Lane 2 and 3: empty, Lane 4: Cholesterol oxidase enzyme digestion with EcoRI and PstI (10 uL). | ||
</p></pie><br> | </p></pie><br> | ||
- | <h4> | + | <h4>BBa_K1313001</h4> |
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/7/7d/Jjj3.png" width="350" height="465" hspace="10" BORDER=10></p><br> |
+ | |||
+ | <p><pie><b>Figure 1.</b> Growth of isolated white colony showing a successful transformation with Oxoacyl-reductase in psB1C3; LB plate with cloramphenicol (35 ug/ml).</p></pie><br> | ||
+ | |||
+ | <p style="text-align: justify; text-justify: inter-word;">The sequence coding for oxoacyl-reductase was subcloned into the BioBrick BBa_J04450, a psB1C3 plasmid containing a coding region for RFP and chloramphenicol resistance as a selection marker. | ||
+ | This ligation was further transformed into E. coli DH5α and grown both on LB plates, and liquid LB media with 1% v/v of antibiotic (35 ug/ml). | ||
+ | A photo of the colonies obtained after replatting the bacteria is shown. This is a valid proof of construction structure, since oxoacyl was previously contained in an ampicillin resistance-containing plasmid and colonies are white. This can only be explained by a functional chloramphenicol resistance (provided by psB1C3 plasmid), and an insertion that occurred in the middle of the RFP-coding region of the backbone. </p><br> | ||
+ | <h4>BBa_K1313002</h4> | ||
+ | |||
+ | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/e/ed/Colo1.jpg" width="400" height="360" hspace="10" BORDER=10></p><br> | ||
<p><pie><b>Figure 1.</b> Growth of white colonies of 7-dehydratase enzyme in psB1C3; LB plate with cloramphenicol (35 ug/ml). </p></pie><br> | <p><pie><b>Figure 1.</b> Growth of white colonies of 7-dehydratase enzyme in psB1C3; LB plate with cloramphenicol (35 ug/ml). </p></pie><br> | ||
Line 301: | Line 313: | ||
<p style="text-align: justify; text-justify: inter-word;">The ligation of 7-dehydratase was made with J04450 (psB1C3 with RFP protein). The BB_J04450 by itself, produces red colonies and grows in the antibiotic Cloramphenicol. After the ligation and transformation, only the white colonies were selected. 7-dehydratase was previously in pUC57 (Ampicillin Resistance), this gives us more certainty that the white colony is in fact, the correct ligation of 7-dehydratase in pSB1C3, otherwise, colonies wouldn’t have grown due to cloramphenicol, or red colonies would have been seen.</p><br> | <p style="text-align: justify; text-justify: inter-word;">The ligation of 7-dehydratase was made with J04450 (psB1C3 with RFP protein). The BB_J04450 by itself, produces red colonies and grows in the antibiotic Cloramphenicol. After the ligation and transformation, only the white colonies were selected. 7-dehydratase was previously in pUC57 (Ampicillin Resistance), this gives us more certainty that the white colony is in fact, the correct ligation of 7-dehydratase in pSB1C3, otherwise, colonies wouldn’t have grown due to cloramphenicol, or red colonies would have been seen.</p><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/4/44/Gel3.png" width="180" height="473" hspace="10" BORDER=10></p><br> |
- | + | ||
<p><pie><b>Figure 2.</b>Gel electrophoresis 0.8% agarose. 7-Dehydratase in pSB1C3 extraction. Lane M: Marker Invitrogen DNA Ladder 1kb Plus (5 uL), Lane 2: Plasmid extraction (5 uL).</p></pie><br> | <p><pie><b>Figure 2.</b>Gel electrophoresis 0.8% agarose. 7-Dehydratase in pSB1C3 extraction. Lane M: Marker Invitrogen DNA Ladder 1kb Plus (5 uL), Lane 2: Plasmid extraction (5 uL).</p></pie><br> | ||
<p style="text-align: justify; text-justify: inter-word;">The image above shows the presence of the correct ligation of 7-dehydratase in pSB1C3.No RNA or protein contamination is to be seen. Nevertheless, the sample concentration is high and less sample should be analyzed in the electrophoresis.</p><br> | <p style="text-align: justify; text-justify: inter-word;">The image above shows the presence of the correct ligation of 7-dehydratase in pSB1C3.No RNA or protein contamination is to be seen. Nevertheless, the sample concentration is high and less sample should be analyzed in the electrophoresis.</p><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/e/e2/Gel33.png" width="600" height="287" hspace="10" BORDER=10></p><br> |
<p><pie><b>Figure 3.</b> In silico restriction analysis of psB1C3 with 7-dehydratase. Three fragments are generated with XhoI. | <p><pie><b>Figure 3.</b> In silico restriction analysis of psB1C3 with 7-dehydratase. Three fragments are generated with XhoI. | ||
Line 313: | Line 324: | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/0/0d/Gel1.png" width="250" height="461" hspace="10" BORDER=10></p><br> |
<p><pie><b>Figure 4.</b>Gel electrophoresis 0.8% agarose. Comprobation of 7- dehydratase in pSB1C3 digestion with Xho I. | <p><pie><b>Figure 4.</b>Gel electrophoresis 0.8% agarose. Comprobation of 7- dehydratase in pSB1C3 digestion with Xho I. | ||
Line 322: | Line 333: | ||
<gotop><a href="#top">Back to top ↑</a></gotop><br><br> | <gotop><a href="#top">Back to top ↑</a></gotop><br><br> | ||
- | <h4> | + | <h4>BBa_K1313003</h4> |
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/b/bf/Colo3.png" width="315" height="315" hspace="10" BORDER=10></p><br> |
<p><pie><b>Figure 1.</b> Growth of red and white colonies of B0034 + Oxoacyl-reductase ligation in pSB1C3; LB plate with cloramphenicol (35 ug/ml).</p></pie><br> | <p><pie><b>Figure 1.</b> Growth of red and white colonies of B0034 + Oxoacyl-reductase ligation in pSB1C3; LB plate with cloramphenicol (35 ug/ml).</p></pie><br> | ||
Line 330: | Line 341: | ||
<p style="text-align: justify; text-justify: inter-word;">The ligation of this enzyme and the RBS B0034 was in J00450, which has the RFP protein encoded. The left half of the Petri dish shows undesired colonies, because they are red-colored. Nonetheles, the right half shows white colonies, representing a succesful ligation of B0034 and Oxoacyl Reductase given the fact that the RFP protein sequence was cut out during this restrction/ligation. </p><br> | <p style="text-align: justify; text-justify: inter-word;">The ligation of this enzyme and the RBS B0034 was in J00450, which has the RFP protein encoded. The left half of the Petri dish shows undesired colonies, because they are red-colored. Nonetheles, the right half shows white colonies, representing a succesful ligation of B0034 and Oxoacyl Reductase given the fact that the RFP protein sequence was cut out during this restrction/ligation. </p><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/1/18/J%C2%B4psd.png" width="600" height="286" hspace="10" BORDER=10></p><br> |
<p><pie><b>Figure 2.</b>In silico restriction analysis of psB1C3 with B0034 + Oxoacyl-Reductase. Two fragments are generated with EcoRI and PstI.</p></pie><br> | <p><pie><b>Figure 2.</b>In silico restriction analysis of psB1C3 with B0034 + Oxoacyl-Reductase. Two fragments are generated with EcoRI and PstI.</p></pie><br> | ||
- | <p> | + | <p class="centeredImage"><img src="https://static.igem.org/mediawiki/2014/5/58/Jjj.png" width="400" height="409" hspace="10" BORDER=10></p><br> |
<p><pie><b>Figure 3.</b> 0.8% agarose gel electrophoresis. B0034 +Oxoacyl in psB1C3 extraction and digestion. Lane 1: 1 Kb plus DNA Ladder Invitrogen (10 ul). Lane 2: B0034 + Oxoacyl Reductase in psB1C3 extraction. Lane 3: B0034 + Oxoacyl Reductase in psB1C3 digestion with EcoRI and PstI | <p><pie><b>Figure 3.</b> 0.8% agarose gel electrophoresis. B0034 +Oxoacyl in psB1C3 extraction and digestion. Lane 1: 1 Kb plus DNA Ladder Invitrogen (10 ul). Lane 2: B0034 + Oxoacyl Reductase in psB1C3 extraction. Lane 3: B0034 + Oxoacyl Reductase in psB1C3 digestion with EcoRI and PstI |
Latest revision as of 03:46, 18 October 2014
ITESM-CEM | Enzy7-K me |
|
||||
Project
|
|||||
| |||||
|
|||||
|